Healthcare entity
health-it is the sole category represented across all 1 tracked stories. Bakkt is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Source depth averages 3 original sources per story, versus 2.5 across the same-window beat baseline.
Last mentioned: Mar 18, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
health-it is the sole category represented across all 1 tracked stories. Bakkt is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Source depth averages 3 original sources per story, versus 2.5 across the same-window beat baseline. At 6, the average consequence score sits above the same-window beat average of 5.8. Inovio appears in 1 tracked Healthcare story from March 18, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 24 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Inovio. Shared-story counts are live from our verified record — not editorial picks.
PDUFA Date
Target date for FDA decision on INO-3107 accelerated approval.
Platform Modernization
LivePerson expects to complete its multiyear platform modernization.
BLA Acceptance
FDA accepts Inovio's BLA for INO-3107 under accelerated approval program.
Inovio Cash Position
Company ends the year with $94.1 million in cash.
Inovio Pharmaceuticals faces a critical regulatory juncture as the FDA accepts its BLA for INO-3107 while questioning its accelerated approval eligibility. Meanwhile, LivePerson is pivoting toward a unified AI architecture with the launch of its Syntrix platform, signaling a shift in how healthcare enterprises may manage patient engagement.
Source: Motley Fool Transcribing (us) · Motley Fool Transcribing (us)
Inovio is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
